Last updated 11 days ago

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

90 patients around the world
Available in Spain, Brazil, United States
Participants screened in the MACARONI-23 Platform study could be randomized to mirikizumab to participate in this intervention specific arm of the study.
Eli Lilly and Company
6Research sites
90Patients around the world
This study is for people with
Crohn's disease
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Sites
Hospital das Clínicas da Universidade Federal de Goiás - UFG
Recruiting
Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050
Instituto de Proteção à Infância Dr. Raul Carneiro
Recruiting
Rua Desembargador Motta, 1070 - Água Verde, Curitiba - PR, 80250-060, Brazil
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Recruiting
Campus Universitário S/N, Bloco G Subsolo II, Monte Alegre, Ribeirão Preto, Sao Paulo
Hospital da Criança Santo Antônio
Recruiting
Av. Independência, 155 - São João, Porto Alegre - RS, 90240-510
Hospital e Maternidade Celso Pierro
Recruiting
Campinas, 13590-900
INTEGRAL Pesquisa e Ensino
Recruiting
Av. da Saudade, 2147 - Parque Res. Friozi, Votuporanga - SP, 15501-405, Brasil
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy